Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. WCN
5. BYD
6. SPOT
7. FIX
8. NDAQ
9. BE
10. BMY

Go back to Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress

Verastem (VSTM) Tops Q3 EPS by 11c

October 29, 2019 4:26 PM EDT

Verastem (NASDAQ: VSTM) reported Q3 EPS of ($0.35), $0.11 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $9.03 million versus the consensus estimate of $8.95 million.

In the third quarter, we achieved $9.0 million in revenue, including $4.0 million in net product revenue from COPIKTRA, a 33% increase over the prior... More